Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CBAY - CymaBay applies for FDA approval of liver disease drug seladelpar

CBAY - CymaBay applies for FDA approval of liver disease drug seladelpar

CymaBay Therapeutics Inc.

2023-12-15 10:08:22 ET

More on CymaBay Therapeutics

For further details see:

CymaBay applies for FDA approval of liver disease drug seladelpar
Stock Information
Company Name: CymaBay Therapeutics Inc.
Stock Symbol: CBAY
Market: NASDAQ
Website: cymabay.com
Menu
CBAY CBAY Quote CBAY Short CBAY News CBAY Articles CBAY Message Board
Get CBAY Alerts

News, Short Squeeze, Breakout and More Instantly...